Revolutionising
Sexual Health
ALGUTIS is on a mission to pioneer
the future of sexual wellness.
​
We're creating a contraceptive gel that also protects against STD's as an alternative medical device to condoms.
​
Our vision is to empower people to take control in protecting themselves against unwanted pregnancy and STDs.
Problem Statement
Condoms remain our only contraceptive option that protect against STDs.
Despite this over-reliance they still only have 82% contraceptive efficiency rate.
Lack protection against skin-to-skin HPV transmission.
​
We need more medical devices alternatives to condoms​.
Statistics
-
80% of people exposed to HPV by 25 and causes 500,000 deaths annually
-
491 Million adults worldwide have HSV-2
-
39 Million adults worldwide have HIV and caused 630,000 deaths in 2022
Sources:​
-
HPV vaccine: How it protects against cervical cancer and who can get it - BBC News
-
The Interaction Between Human Papillomavirus and Other Viruses - PMC (nih.gov)
-
900-world-fact-sheet.pdf (who.int)
Our Solution
Seasilk is composed of 2 key ingredients
GlycoProtein
A novel glycoprotein that's demonstrated
reduction of HSV-2 & HIV-1 transmission
and antibacterial properties
Polysaccaride
A marine-sourced polysaccharide that has demonstrated reduced transmission against several HPV strains
Both ingredients mechanism of action work through binding
to viral particles, reducing transmission
Contact Us
Reach out on LinkedIn: www.linkedin.com/in/samuel-shannon-biochemlove/
Or fill out the form below and we'll get in contact as soon as possible!